Article
MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy
28 Jan 2018
Abstract excerpt
An individual tumor can present intratumoral phenotypic heterogeneity, containing tumor cells with different phenotypes that do not present irreversible genetic alterations. We have developed a mouse cancer model, named GR9, derived from a methylcholanthrene-induced fibrosarcoma that was adapted to tissue culture and cloned into different tumor cell lines. The clones showed diverse MHC-I phenotypes, ranging from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
